Filtros de búsqueda

Lista de obras de J Wrin

Can we accurately report PTEN status in advanced colorectal cancer?

artículo científico publicado en 2014

Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer

artículo científico publicado en 2015

Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk.

artículo científico publicado en 2016

High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab.

artículo científico publicado en 2016

High-affinity monoclonal antibodies against P-glycoprotein.

artículo científico publicado en 1995

Identification of a Cell Surface Protein with a Role in Stimulating Human Keratinocyte Proliferation, Expressed During Development and Carcinogenesis ⬇️

artículo científico publicado el 1 de agosto de 1997

Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.

artículo científico publicado en 2011

Measurement of an analog of insulin-like growth factor-I in blood plasma using a novel enzyme-linked immunosorbent assay

artículo científico publicado en 1998

Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cells.

artículo científico publicado en 2014

Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro

artículo científico publicado en 2016

Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer

artículo científico publicado en 2014

Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab.

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda